Zacks highlights research reports on JPMorgan, Novartis, Qualcomm, Genie Energy, and ImmuCell

Industry
โดย Zacks Investment Research·Read original
Summary · why it matters

Zacks Equity Research released new research reports on 16 major stocks, including JPMorgan Chase, Novartis, and Qualcomm, along with micro-cap companies Genie Energy and ImmuCell. JPMorgan's consumer franchise continues to expand with U.S. branch builds and planned Chase digital expansion in Europe, though elevated expenses and a tough macro backdrop raise asset quality concerns. Novartis faces a challenging 2026 due to the largest patent cliff in its history from Entresto generic competition, but its strong portfolio including Kisqali and Pluvicto supports mid-term growth. Qualcomm is pivoting toward a broader connected processor portfolio with solid automotive traction, yet handset demand uncertainty and increasing in-house chip development by OEMs could pressure market share. Genie Energy, a microcap with a market capitalization of $386.24 million, is repositioning its renewables platform toward owned-generation assets while managing margin pressure from commodity volatility. ImmuCell, a microcap with a market capitalization of $88.57 million, continues to gain market share in calf scours prevention through manufacturing improvements and a focus on its First Defense product line.

Impact on stocks 5

Biotech & Genomic Medicine▼ · 1 stocks
Novartis AG
NOVN
▼ NegativeCompetitionrelevance

Faces largest patent cliff in its history from Entresto generic competition, though strong portfolio supports mid-term growth.

Digital Finance & Tokenization▲ · 1 stocks
JPMorgan Chase & Co
JPM
± MixedDemandrelevance

Consumer franchise expanding with branch builds and digital expansion, but elevated expenses and tough macro backdrop raise asset quality concerns.

Semiconductors▲ · 1 stocks
Qualcomm Incorporated
QCOM
± MixedTechnologyrelevance

Pivoting toward broader connected processor portfolio with solid automotive traction, but handset demand uncertainty and in-house chip development by OEMs could pressure market share.

Health Care▲ · 1 stocks
ImmuCell Corporation
ICCC
▲ PositiveDemandrelevance

Gaining market share in calf scours prevention through manufacturing improvements and focus on First Defense product line.

Energy Transition & Power Demand▲ · 1 stocks
Genie Energy Ltd
GNE
± MixedSupplyrelevance

Repositioning toward owned-generation assets while managing margin pressure from commodity volatility.

© 2026 MarketDXNews